Coegin Pharma AB (NGM:COEGIN)
Sweden · Delayed Price · Currency is SEK 2.210
+0.040 (1.84%)
At close: Oct 19, 2026
Coegin Pharma AB Revenue
Coegin Pharma AB had revenue of 62.00K SEK in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 433.00K. In the year 2025, Coegin Pharma AB had annual revenue of 79.00K. That makes Coegin Pharma AB the 46,634th largest company in the world by revenue and 756th in Sweden.
Revenue (ttm)
433.00K
Revenue Growth
n/a
P/S Ratio
143.29
Revenue / Employee
n/a
Employees
3
Market Cap
63.19M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 79.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NGS Group AB | 272.33M |
| Transfer Group AB | 216.24M |
| ABAS Protect AB | 91.93M |
| Mediacle Group AB | 51.63M |
| Suntrade Group AB | 7.68M |
| Cardeon AB | 3.27M |
| Railway Metrics and Dynamics Sweden AB | 2.88M |
| Katalysen Ventures AB | 2.41M |
Coegin Pharma AB News
- 2 months ago - Coegin Pharma AB Quarterly report: Q2 2026 - Filings
- 5 months ago - Coegin Pharma AB Quarterly report: Q1 2026 - Filings
- 7 months ago - Coegin Pharma AB Quarterly report: Q4 2025 - Filings
- 7 months ago - Coegin Pharma AB Annual report: Q4 2025 - Filings
- 11 months ago - Coegin Pharma AB Quarterly report: Q3 2025 - Filings